Product image of Glimepirid 1 A Pharma (Glimepiride) supplied by GNH India

Glimepirid 1 A Pharma

Active Ingredient:
Glimepiride
Origin:
EU

Glimepirid 1 A Pharma (Glimepiride)

Glimepirid 1 A Pharma is a product that contains the active ingredient glimepiride, supplied as an oral tablet for the EU market. It belongs to the sulfonylurea class of antidiabetic agents and is available by prescription. The medication works by stimulating insulin release from pancreatic beta‑cells, helping to lower blood glucose in patients with type 2 diabetes mellitus. Glimepirid 1 A Pharma complies with EU guidelines and is used for glycemic control.

Manufacturer / TM Owner

1 A Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glimepirid 1 A Pharma is indicated for the management of elevated blood glucose in adults with type 2 diabetes mellitus, typically as an adjunct to diet and exercise.

  • Used as monotherapy when diet, exercise, and other oral agents are insufficient.
  • Combined with metformin or other antidiabetic agents to improve glycemic control.
  • May be prescribed when patients have stable renal function and no contraindications to sulfonylureas.
  • Helpful in patients who require a once‑daily oral medication.
  • Considered for individuals who need additional post‑prandial glucose reduction.

Side Effects

The safety profile of glimepiride includes a range of observed effects that vary in frequency and severity.

Common

  • Low blood sugar (hypoglycemia), especially if meals are missed.
  • Weight gain due to increased insulin activity.
  • Nausea or mild gastrointestinal discomfort.
  • Headache or dizziness.

Serious

  • Severe hypoglycemia leading to loss of consciousness.
  • Allergic reactions such as skin rash, swelling, or anaphylaxis.

Precautions & Warnings

Before initiating Glimepirid 1 A Pharma, clinicians should evaluate several precautionary factors to ensure safe use.

  • Assess renal and hepatic function; dose adjustments may be needed in impairment.
  • Review patient history for prior sulfonylurea hypersensitivity or severe hypoglycemia.
  • Use caution in elderly patients who are more prone to low blood sugar.
  • Avoid use during pregnancy and breastfeeding unless benefits outweigh risks.
  • Monitor blood glucose regularly after dose changes.
  • Consider cardiovascular status, as sulfonylureas may affect ischemic preconditioning.

Avoid Interactions

Glimepirid 1 A Pharma can interact with other medicines, altering its effectiveness or increasing adverse effects.

Avoid

  • Concomitant use with other sulfonylureas or insulin may cause additive hypoglycemia.
  • Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) can raise glimepiride levels.

Use with caution

  • Beta‑blockers may mask hypoglycemia symptoms.
  • Thiazide diuretics can increase blood glucose variability.
  • NSAIDs may affect renal function, influencing drug clearance.
  • Antidepressants such as SSRIs may alter glycemic control.

Frequently Asked Questions

Glimepiride binds to the sulfonylurea receptor (SUR1) on pancreatic beta‑cells, closing ATP‑dependent potassium channels and promoting insulin secretion, which lowers blood glucose levels.

It is prescribed as a once‑daily oral tablet, usually taken with breakfast. The exact dose is individualized based on glycemic response and patient characteristics.

Glimepirid 1 A Pharma may be taken with or without food; taking it with a meal can help reduce the risk of hypoglycemia.

Common signs include sweating, shakiness, rapid heartbeat, dizziness, hunger, confusion, and, in severe cases, loss of consciousness.

Renal function should be evaluated before starting therapy. Dose reduction or alternative treatment may be required for moderate to severe renal impairment.

Patients are generally advised to check fasting and post‑prandial glucose regularly, especially after dose adjustments, to ensure target levels are achieved without hypoglycemia.

Yes, combining glimepiride with metformin is a common strategy to improve glycemic control, provided the combination is prescribed and monitored by a healthcare professional.

Avoid skipping meals after a dose, using other sulfonylureas or insulin without medical guidance, and consuming alcohol excessively, as these can increase hypoglycemia risk.

Glimepirid 1 A Pharma is generally not recommended during pregnancy; alternative insulin therapy is preferred unless the potential benefit justifies the risk.

Elderly patients may be more sensitive to hypoglycemia; clinicians often start with a lower dose and titrate cautiously.

The most frequently reported side effects are hypoglycemia, weight gain, nausea, headache, and mild dizziness.

CYP2C9 inhibitors can increase plasma concentrations of glimepiride, raising the risk of hypoglycemia; dose adjustments or alternative therapy may be needed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glimepiride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT